featured
High-Dose Dexamethasone Plus Recombinant Human Thrombopoietin vs High-Dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary ITP
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Hematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
High-Dose Dexamethasone Plus Recombinant Human Thrombopoietin Versus High-Dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial
Am. J. Hematol 2020 Sep 01;[EPub Ahead of Print], Y Yu, M Wang, Y Hou, P Qin, Q Zeng, W Yu, X Guo, J Wang, X Wang, G Liu, X Chu, L Yang, Y Feng, F Zhou, Z Sun, M Zhang, X Wang, Z Wang, X Ran, H Zhao, L Wang, H Zhang, K Bi, D Li, C Yuan, R Xu, Y Wang, Y Zhou, J Peng, XG Liu, M HouFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.